MYCOPHENOLATE

MYCOPHENOLATE (14071N)

mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
14071N
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $432.14 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
CellCept
Pharmacor Mycophenolate

MYCOPHENOLATE (6364Y)

mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
6364Y
Body System:
Manner of administration:Oral
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9691)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9693)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $399.12 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
CellCept
Pharmacor Mycophenolate

MYCOPHENOLATE (8651H)

mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
8651H
Body System:
Manner of administration:Oral
General Schedule
No restrictions
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $222.04 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
CellCept
Pharmacor Mycophenolate

MYCOPHENOLATE (9500B)

mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL
9500B
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 5795)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 5554)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $372.20 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
CellCept
Pharmacor Mycophenolate